Dec 13 (Reuters) - ESSA Pharma Inc EPIX.O :
* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30,
2022
* ESSA PHARMA INC - NET LOSS FOR Q4 ENDED SEPTEMBER 30, 2022
WAS
$6.3 MILLION COMPARED TO A NET LOSS OF $8.5 MILLION FOR Q4 ENDED
SEPTEMBER 30, 2021
* ESSA PHARMA INC - COMPANY'S CASH POSITION IS EXPECTED TO
BE
SUFFICIENT TO FUND CURRENT AND PLANNED OPERATIONS THROUGH 2025
Source text for Eikon: ID:nPncgvCQya
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))